Heidi M. Mansour, PhD, R.Ph. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Heidi M. Mansour, PhD, R.Ph.


Heidi Mansour Pharmtech editorial advisory board (EAB) member

Heidi M. Mansour, PhD, R.Ph.
Assistant Professor of Pharmaceutics & Drug Delivery, UK College of Pharmacy
Faculty Associate, UK Center of Membrane Sciences

 

Dr. Mansour currently holds faculty appointments and graduate appointments at the University of Kentucky (UK) College of Pharmacy,  is a graduate faculty member at the University of North Carolina-Chapel Hill (UNC-Chapel Hill), and faculty associate of the UK Membrane Center.  She is a faculty mentor in the UK Engineered Bioactive Interfaces and Devices Program funded through the National Science Foundation Integrative Graduate Education Research Training (NSF IGERT) Program and the NSF Research Education for Undergraduates (NSF REU) Training Program joint with the UK College of Engineering.  She is also a faculty mentor in the National Cancer Institute-Cancer Nanotechnology Training Center (NCI-CNTC).

Previously, she was an instructor (both in the graduate and Pharm.D. programs) and a postdoctoral fellow at UNC-Chapel Hill School of Pharmacy in the Division of Molecular Pharmaceutics receiving the 2007 UNC-Chapel Hill Postdoctoral Award for Research Excellence from the Office of the Vice-Chancellor and the 2007 AAPS Postdoctoral Fellow Award in Research Excellence. She has a BS in pharmacy (highest honors & distinction) and a PhD in pharmaceutical sciences with a PhD major in drug delivery/pharmaceutics (School of Pharmacy-2003) and a PhD minor in advanced physical & biophysical chemistry (Dept. of Chemistry-1999) from the University of Wisconsin-Madison.  She has an active research program on targeted pulmonary inhalation aerosol delivery systems, novel aerosol formulation and device design, lung surfactant replacement, and pulmonary nanomedicine for the treatment and prevention of many pulmonary diseases.

Dr. Mansour is an active long-time member of many professional organizations (please see websites below for details).  She serves on the journal Editorial Advisory Boards of  Pharmaceutical Technology North America, Journal of Nanomedicine & Nanotechnology, Journal of Nanotechnology & Biotherapeutic Discovery, Recent Patents on Nanomedicine,  Recent Patents on Drug Delivery & Formulation, Medicinal Chemistry: Current Research, Journal of Pharmaceutical Technology & Drug Research (United Kingdom).  In addition, she serves as a Delegate to the United States Pharmacopeia (USP) and on the  NIH/NICHD U.S. Pediatric Formulations Initiative (PFI) New Drug Delivery Systems (NDDS) Aerosols Working Group.  She regularly serves as an expert reviewer for nearly 40 scientific journals and several book publishers including Elsevier, Pharmaceutical Press-The Royal Pharmaceutical Society of Great Britain, Marcel Dekker, Springer, and Wiley-Interscience.

Dr. Mansour has published over 40 peer-reviewed scientific publications, invited papers, 5 book chapters, and is Co-Editor of a new book on nanomedicine drug delivery by Taylor & Francis/CRC Press.  She leads a multi-disciplinary group of postdoctoral scholars, visiting scholars/visiting professors, graduate students, physician-scientist fellows, and undergraduate students.

 

More information can be found on her websites:

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here